Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and Risks

Citations Over TimeTop 10% of 2002 papers

Abstract

The present study examined reasons for the high incidence of hepatitis C virus (HCV) infection among young injection drug users (IDUs). IDUs <30 years old who tested negative for HCV antibody were enrolled in a prospective cohort. Risk factors for seroconversion were examined using time-dependent regression analyses: 48 of 195 IDUs seroconverted to HCV, for an incidence rate of 25.1/100 person-years (95% confidence interval, 18.7-32.9/100 person-years). Independent risk factors included sharing needles with an HCV-infected sex partner (borderline statistical significance, P=.11) or a person who was not a sex partner, sharing nonsterile drug-preparation equipment, pooling money with another IDU to buy drugs, and exchanging sex for money. Ubiquitous behaviors among young IDUs, such as the forming of injecting or sexual partnerships and consequent sharing of needles and drug preparation equipment, are risk factors for HCV. Interventions to reduce HCV transmission must recognize the importance of relationships on injecting risk.

Related Papers

• → Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels(2013)180 cited
• → Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities(2010)128 cited
• → Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men.(1990)149 cited
• → Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users(1992)54 cited
• → Failure of Hepatitis C Therapy in HIV‐Coinfected Drug Users Is Not Due to a Shift in Hepatitis C Virus Genotype(2005)8 cited